ArticleJCI insight2019

Safety and early efficacy outcomes for lentiviral fibroblast gene therapy in recessive dystrophic epidermolysis bullosa.

Su M Lwin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.